Harmony Biosciences (HRMY) News Today $29.41 +0.51 (+1.78%) As of 01:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Harmony Biosciences (HRMY) Projected to Post Quarterly Earnings on TuesdayHarmony Biosciences (NASDAQ:HRMY) will be releasing its Q1 2025 earnings before the market opens on Tuesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-4-29-harmony-biosciences-holdings-inc-stock/)April 24 at 5:51 AM | marketbeat.comFirst Week of June 20th Options Trading For Harmony Biosciences Holdings (HRMY)April 24 at 12:06 AM | nasdaq.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Sees Significant Decline in Short InterestHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) was the recipient of a significant decline in short interest in March. As of March 31st, there was short interest totalling 3,490,000 shares, a decline of 15.1% from the March 15th total of 4,110,000 shares. Approximately 8.0% of the shares of the stock are short sold. Based on an average trading volume of 683,500 shares, the days-to-cover ratio is presently 5.1 days.April 23 at 5:09 AM | marketbeat.comInvesco Ltd. Raises Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Invesco Ltd. increased its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 173.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 449,180 shares of the company's stock after buyiApril 22 at 3:31 AM | marketbeat.comHarmony Biosciences price target lowered to $32 from $33 at BofAApril 22 at 1:46 AM | markets.businessinsider.comBank of America Securities Sticks to Its Sell Rating for Harmony Biosciences Holdings (HRMY)April 22 at 1:46 AM | markets.businessinsider.comMarshall Wace LLP Has $31.99 Million Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Marshall Wace LLP lifted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 165.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 929,744 shares of the company's stockApril 21 at 5:24 AM | marketbeat.comGeode Capital Management LLC Has $31.08 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Geode Capital Management LLC increased its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 22.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 902,934 shares of the company's stoApril 19, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Stock Price Down 4.6% - Here's What HappenedHarmony Biosciences (NASDAQ:HRMY) Stock Price Down 4.6% - What's Next?April 17, 2025 | marketbeat.comFmr LLC Buys 101,182 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Fmr LLC boosted its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 1.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,329,902 shares of the company's stockApril 15, 2025 | marketbeat.comRenaissance Technologies LLC Grows Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Renaissance Technologies LLC lifted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 15.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 568,671 shares of the company's stockApril 15, 2025 | marketbeat.comLSV Asset Management Buys 184,026 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)LSV Asset Management lifted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 23.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 956,217 shares of the cApril 14, 2025 | marketbeat.comFederated Hermes Inc. Sells 49,276 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Federated Hermes Inc. cut its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 9.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 492,803 shares of the company's stApril 12, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Receives Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $70.00 target price on shares of Harmony Biosciences in a research report on Tuesday.April 10, 2025 | marketbeat.comNeedham & Company LLC Reiterates Buy Rating for Harmony Biosciences (NASDAQ:HRMY)Needham & Company LLC reaffirmed a "buy" rating and set a $50.00 price target on shares of Harmony Biosciences in a research note on Tuesday.April 10, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Sets New 52-Week Low - Should You Sell?Harmony Biosciences (NASDAQ:HRMY) Sets New 52-Week Low - Here's What HappenedApril 9, 2025 | marketbeat.comNorges Bank Invests $16.12 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Norges Bank acquired a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 468,410 shares of the company's stock, valued at approximately $16April 9, 2025 | marketbeat.com6HRMY : Breaking Down Harmony Biosciences...April 8, 2025 | benzinga.comHarmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X SyndromeApril 8, 2025 | finance.yahoo.comHarmony Biosciences Appoints Ron Philip to Board of DirectorsApril 8, 2025 | msn.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA increased its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 25.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 829,620 shareApril 8, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Holdings Increased by Vanguard Group Inc.Vanguard Group Inc. boosted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 36.4% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,733,609 shares of the company's stock after purchasing an aApril 8, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Consensus Recommendation of "Buy" by AnalystsHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) has been given a consensus recommendation of "Buy" by the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1-yApril 8, 2025 | marketbeat.comTrexquant Investment LP Makes New Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Trexquant Investment LP acquired a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 175,574 shares of the company's stock, valued at approximately $6,042,000. TrexquaApril 7, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Has $10.21 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Arrowstreet Capital Limited Partnership reduced its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 6.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 296,618 shApril 7, 2025 | marketbeat.comPrudential Financial Inc. Buys 28,650 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Prudential Financial Inc. raised its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 91.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,911 shares of the company's stock after buying aApril 6, 2025 | marketbeat.comRaymond James Financial Inc. Invests $1.30 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Raymond James Financial Inc. purchased a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 37,907 shares of the company's stock, valued at approximately $1,April 4, 2025 | marketbeat.comHarmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of DirectorsApril 3, 2025 | businesswire.comKLP Kapitalforvaltning AS Invests $791,000 in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)KLP Kapitalforvaltning AS purchased a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 23,000 shares of theApril 2, 2025 | marketbeat.comHighTower Advisors LLC Has $392,000 Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)HighTower Advisors LLC reduced its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 85.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,401 shares of the coApril 2, 2025 | marketbeat.com49,632 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Bought by New Age Alpha Advisors LLCNew Age Alpha Advisors LLC acquired a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 49,632 shares of the compaApril 1, 2025 | marketbeat.comHarmony Biosciences to Present at 24th Annual Needham Virtual Healthcare ConferenceMarch 31, 2025 | msn.comAmerican Century Companies Inc. Increases Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)American Century Companies Inc. grew its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 28.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,102,604 shares of theMarch 29, 2025 | marketbeat.comBronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Stockholders to ConnectMarch 28, 2025 | markets.businessinsider.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by Swiss National BankSwiss National Bank boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 28.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 78,200 shares of the company's stock after purchasingMarch 28, 2025 | marketbeat.comMizuho Securities Sticks to Their Buy Rating for Harmony Biosciences Holdings (HRMY)March 28, 2025 | markets.businessinsider.comHarmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare ConferenceMarch 26, 2025 | businesswire.comEntryPoint Capital LLC Makes New Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)EntryPoint Capital LLC acquired a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 32,084 shares of the company's stock, vaMarch 26, 2025 | marketbeat.comProficio Capital Partners LLC Invests $367,000 in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Proficio Capital Partners LLC bought a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 10,667 shares oMarch 26, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Shares Down 3.2% - Time to Sell?Harmony Biosciences (NASDAQ:HRMY) Stock Price Down 3.2% - Time to Sell?March 25, 2025 | marketbeat.comHarmony Biosciences: A Compelling Risk-Reward OpportunityMarch 24, 2025 | seekingalpha.comHarmony Biosciences CCO Jeffrey Dierks steps down, Adam Zaeske succeedsTakedaMarch 24, 2025 | markets.businessinsider.comHarmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio ExpandsMarch 24, 2025 | businesswire.comBridge City Capital LLC Increases Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Bridge City Capital LLC raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 28.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 103,809 shares of the company's stock after acquiring an additional 22,7March 24, 2025 | marketbeat.comSummit Global Investments Boosts Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Summit Global Investments lifted its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 57.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,290 shares of the company's stock aftMarch 24, 2025 | marketbeat.comHRMY Investors Have Opportunity to Join Harmony Biosciences Holdings, Inc. Fraud Investigation with the Schall Law FirmMarch 21, 2025 | businesswire.comAmundi Acquires 13,041 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Amundi raised its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 243.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,402 shares of the company's stock after purMarch 21, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Purchases 100,586 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Charles Schwab Investment Management Inc. grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 27.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 472,028 shares of the coMarch 21, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Price Target Raised to $44.00Mizuho raised their target price on shares of Harmony Biosciences from $42.00 to $44.00 and gave the stock an "outperform" rating in a report on Tuesday.March 19, 2025 | marketbeat.comExpert Outlook: Harmony Biosciences Hldgs Through The Eyes Of 11 AnalystsMarch 18, 2025 | benzinga.com Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address HRMY Media Mentions By Week HRMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HRMY News Sentiment▼1.220.72▲Average Medical News Sentiment HRMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HRMY Articles This Week▼106▲HRMY Articles Average Week Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BridgeBio Pharma News Legend Biotech News TG Therapeutics News Telix Pharmaceuticals Limited American Depositary Shares News Blueprint Medicines News Sarepta Therapeutics News Axsome Therapeutics News Nuvalent News Verona Pharma News Grifols News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HRMY) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredTrump’s treachery Intuitive Surgical at $1.99. Nvidia at $11. Shorting Fannie Mae months before collapse. That’s this analyst’s ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
